Sign In

Barbara Krebs-Pohl

Chief Business Officer at MorphoSys

Barbara Krebs-Pohl is a seasoned professional with over 25 years of experience in the science and medicine industry, primarily at MorphoSys where she has excelled in various roles from scientist to company executive.

She currently holds the position of Chief Business Officer at MorphoSys, where she plays a crucial role in driving business growth and establishing strategic partnerships to bring innovative medicines to individuals battling life-threatening diseases.

Barbara's leadership was instrumental in the successful acquisition and integration of Constellation Pharmaceuticals into MorphoSys, solidifying the company's oncology leadership and extending its pipeline to address unmet medical needs.

With a strong belief in mentorship, Barbara values the guidance she received throughout her career and actively encourages young women entering the workforce to seek mentors and pursue impactful careers in their chosen fields.

Recognizing the importance of fostering a supportive work environment, Barbara prioritizes creating a culture of respect, openness, and trust within her teams to ensure that every individual, regardless of background, feels valued and included.

Her educational background includes a range of prestigious institutions such as Harvard Business School, University of Cambridge, Johannes Gutenberg University Mainz, RWTH Aachen University, and University of Cologne, where she has pursued studies in business administration, antibody phage display, and chemistry.

Barbara has held various key positions at MorphoSys, including Chief Business Officer, Chief Integration Officer, Senior Vice President, Head of Global BD&L & Alliance Management, and Director of Business Development among others, showcasing her versatile expertise across different domains within the organization.

Barbara Krebs-Pohl
Add to my network

Location

Greater Munich Metropolitan Area